Funding for this research was provided by:
National Science Foundation (CBET-1645123, AWD-101645-G3 / RJ375-G3, CBET-1645123)
National Institutes of Health (1R35GM119644-01)
National Cancer Institute (R01 CA215461)
St. Baldrick's Foundation (SU2C-AACR-DT-27-17)
American Cancer Society (RSG-18-104-01-LIB)
Article History
Received: 23 January 2020
Revised: 16 May 2020
Accepted: 25 May 2020
First Online: 16 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CMC reports honorarium from an advisory board for Nektar Therapeutics. The other authors declare no competing interests.